Pella, Who Provided Information To Investigators And Has Not Been Charged, Concluded Then That Three Out Of Five Plant Strains In New York Could Not Produce The Correct Amount Of Thc Or Cbd, The Active Ingredients In Medical Marijuana.

New York required companies to conduct all parts of their operations, from growing the plants to selling the medicines, within the state. A spokesman for Vireo Health said the company has cooperated with the investigation and will continue to do so. “When we became aware of the possibility that one or more individuals may have acted in ways contrary to the laws of the state and to our own policies and procedures, we acted immediately to investigate the allegations, communicate with our regulators and take appropriate action,” the spokesman said. According to an investigation by the Minnesota Bureau of Criminal Apprehension, former MMS Chief Scientific Officer Daniel Pella visited Vireo Health’s Fulton County facility in December 2015 to oversee marijuana the cultivation of marijuana plants. Pella, who provided information to investigators and has not been charged, concluded then that three out of five plant strains in New York could not produce the correct amount of THC or CBD, the active ingredients in medical marijuana. He specifically noted a lack of “red” strains, the company’s label for those that are THC-dominant. Bultman and Shimpa directed Pella to identify THC oils in jars that would “rescue New York,” according to court filings. Pella told investigators that he believed the jars, estimated to be worth $500,000, made it to New York, where they were converted to capsules and vaporizers to be sold as medicine. Pella was fired in April.

To read more visit

Comments are closed.